首页> 美国卫生研究院文献>Journal of Nanobiotechnology >Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches
【2h】

Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches

机译:通过肿瘤靶向的白蛋白-量子点纳米杂化剂结合亲水化学疗法和疏水植物疗法:共价偶联和磷脂络合方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe rationale of this study is to combine the merits of both albumin nanoparticles and quantum dots (QDs) in improved drug tumor accumulation and strong fluorescence imaging capability into one carrier. However, premature drug release from protein nanoparticles and high toxicity of QDs due to heavy metal leakage are among challenging hurdles. Following this platform, we developed cancer nano-theranostics by coupling biocompatible albumin backbone to CdTe QDs and mannose moieties to enhance tumor targeting and reduce QDs toxicity. The chemotherapeutic water soluble drug pemetrexed (PMT) was conjugated via tumor-cleavable bond to the albumin backbone for tumor site-specific release. In combination, the herbal hydrophobic drug resveratrol (RSV) was preformulated as phospholipid complex which enabled its physical encapsulation into albumin nanoparticles.
机译:背景这项研究的基本原理是将白蛋白纳米颗粒和量子点(QD)的优点结合在一起,以改善药物肿瘤的积累和强大的荧光成像能力,并将其整合到一个载体中。然而,从蛋白质纳米颗粒中过早释放药物和由于重金属泄漏引起的量子点的高毒性是具有挑战性的障碍。通过该平台,我们通过将生物相容性白蛋白骨架与CdTe QD和甘露糖部分偶联以增强肿瘤靶向性并降低QD毒性,从而开发出了癌症纳米治疗剂。通过肿瘤可裂解键将化学治疗水溶性培美曲塞(PMT)缀合至白蛋白骨架,以实现肿瘤部位特异性释放。在组合中,草药疏水性药物白藜芦醇(RSV)被预先配制为磷脂复合物,从而使其能够物理包封到白蛋白纳米颗粒中。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号